{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:31:31Z","timestamp":1790685091843,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12943-014-0278-9","type":"journal-article","created":{"date-parts":[[2015,1,26]],"date-time":"2015-01-26T16:07:51Z","timestamp":1422288471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death"],"prefix":"10.1186","volume":"14","author":[{"given":"Elin Hallan","family":"Naderi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seham","family":"Skah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hege","family":"Ugland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Myklebost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagny Lise","family":"Sandnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lyngaas","family":"Torgersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Josefsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Ruud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Naderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi Kiil","family":"Blomhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,27]]},"reference":[{"key":"278_CR1","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","volume":"381","author":"H Inaba","year":"2013","unstructured":"Inaba H, Greaves M, Mullighan CG. Acute lymphoblastic leukaemia. Lancet. 2013;381:1943\u201355.","journal-title":"Lancet"},{"key":"278_CR2","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","volume":"30","author":"SP Hunger","year":"2012","unstructured":"Hunger SP, Lu X, Devidas M, Camitta BM, Gaynon PS, Winick NJ, et al. Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group. J Clin Oncol. 2012;30:1663\u20139.","journal-title":"J Clin Oncol"},{"key":"278_CR3","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1056\/NEJMoa0900386","volume":"360","author":"CH Pui","year":"2009","unstructured":"Pui CH, Campana D, Pei D, Bowman WP, Sandlund JT, Kaste SC, et al. Treating childhood acute lymphoblastic leukemia without cranial irradiation. N Engl J Med. 2009;360:2730\u201341.","journal-title":"N Engl J Med"},{"key":"278_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1182\/asheducation-2011.1.238","volume":"2011","author":"LL Robison","year":"2011","unstructured":"Robison LL. Late effects of acute lymphoblastic leukemia therapy in patients diagnosed at 0-20 years of age. Hematology Am Soc Hematol Educ Program. 2011;2011:238\u201342.","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"278_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1517\/14656566.2013.804911","volume":"14","author":"P Zerra","year":"2013","unstructured":"Zerra P, Cochran TR, Franco VI, Lipshultz SE. An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies. Expert Opin Pharmacother. 2013;14:1497\u2013513.","journal-title":"Expert Opin Pharmacother"},{"key":"278_CR6","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/MPH.0000000000000000","volume":"36","author":"PK Duffner","year":"2014","unstructured":"Duffner PK, Armstrong FD, Chen L, Helton KJ, Brecher ML, Bell B, et al. Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group. J Pediatr Hematol Oncol. 2014;36:8\u201315.","journal-title":"J Pediatr Hematol Oncol"},{"issue":"6","key":"278_CR7","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1097\/MPH.0000000000000051","volume":"36","author":"B Zeller","year":"2013","unstructured":"Zeller B, Loge JH, Kanellopoulos A, Hamre H, Wyller VB, Ruud E. Chronic fatigue in long-term survivors of childhood lymphomas and leukemia: persistence and associated clinical factors. J Pediatr Hematol Oncol. 2013;36(6):438\u201344.","journal-title":"J Pediatr Hematol Oncol"},{"key":"278_CR8","first-page":"42","volume":"6","author":"P Fenaux","year":"1992","unstructured":"Fenaux P, Jonveaux P, Quiquandon I, Preudhomme C, Lai JL, Vanrumbeke M, et al. Mutations of the p53 gene in B-cell lymphoblastic acute leukemia: a report on 60 cases. Leukemia. 1992;6:42\u20136.","journal-title":"Leukemia"},{"key":"278_CR9","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1182\/blood-2009-02-204883","volume":"114","author":"EH Naderi","year":"2009","unstructured":"Naderi EH, Findley HW, Ruud E, Blomhoff HK, Naderi S. Activation of cAMP signaling inhibits DNA damage-induced apoptosis in BCP-ALL cells through abrogation of p53 accumulation. Blood. 2009;114:608\u201318.","journal-title":"Blood"},{"key":"278_CR10","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1593\/neo.11542","volume":"13","author":"EH Naderi","year":"2011","unstructured":"Naderi EH, Jochemsen AG, Blomhoff HK, Naderi S. Activation of cAMP signaling interferes with stress-induced p53 accumulation in ALL-derived cells by promoting the interaction between p53 and HDM2. Neoplasia. 2011;13:653\u201363.","journal-title":"Neoplasia"},{"key":"278_CR11","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1182\/blood-2012-08-452698","volume":"121","author":"EH Naderi","year":"2013","unstructured":"Naderi EH, Ugland HK, Diep PP, Josefsen D, Ruud E, Naderi S, et al. Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL. Blood. 2013;121:1805\u201313.","journal-title":"Blood"},{"key":"278_CR12","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/978-3-540-72843-6_14","volume":"186","author":"KM Torgersen","year":"2008","unstructured":"Torgersen KM, Aandahl EM, Tasken K. Molecular architecture of signal complexes regulating immune cell function. Handb Exp Pharmacol. 2008;186:327\u201363.","journal-title":"Handb Exp Pharmacol"},{"key":"278_CR13","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.4049\/jimmunol.138.4.1074","volume":"138","author":"NJ Simkin","year":"1987","unstructured":"Simkin NJ, Jelinek DF, Lipsky PE. Inhibition of human B cell responsiveness by prostaglandin E2. J Immunol. 1987;138:1074\u201381.","journal-title":"J Immunol"},{"key":"278_CR14","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/0167-5699(88)91220-0","volume":"9","author":"GM Kammer","year":"1988","unstructured":"Kammer GM. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol Today. 1988;9:222\u20139.","journal-title":"Immunol Today"},{"key":"278_CR15","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646\u201374.","journal-title":"Cell"},{"key":"278_CR16","first-page":"321","volume":"2013","author":"P Barcellos-de-Souza","year":"1836","unstructured":"Barcellos-de-Souza P, Gori V, Bambi F, Chiarugi P. Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta. 1836;2013:321\u201335.","journal-title":"Biochim Biophys Acta"},{"key":"278_CR17","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1126\/science.1099513","volume":"306","author":"J Houghton","year":"2004","unstructured":"Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, et al. Gastric cancer originating from bone marrow-derived cells. Science. 2004;306:1568\u201371.","journal-title":"Science"},{"key":"278_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12984","volume":"505","author":"SJ Morrison","year":"2014","unstructured":"Morrison SJ, Scadden DT. The bone marrow niche for haematopoietic stem cells. Nature. 2014;505:327\u201334.","journal-title":"Nature"},{"key":"278_CR19","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10238-012-0176-7","volume":"13","author":"D Zeng","year":"2013","unstructured":"Zeng D, Hao L, Xu W, Li Z, Li W, Li J, et al. Pinch-1 was up-regulated in leukemia BMSC and its possible effect. Clin Exp Med. 2013;13:21\u20137.","journal-title":"Clin Exp Med"},{"key":"278_CR20","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1182\/blood-2010-12-326694","volume":"118","author":"AH Nwabo Kamdje","year":"2011","unstructured":"Nwabo Kamdje AH, Mosna F, Bifari F, Lisi V, Bassi G, Malpeli G, et al. Notch-3 and Notch-4 signaling rescue from apoptosis human B-ALL cells in contact with human bone marrow-derived mesenchymal stromal cells. Blood. 2011;118:380\u20139.","journal-title":"Blood"},{"key":"278_CR21","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1182\/blood-2012-06-437988","volume":"122","author":"VL Battula","year":"2013","unstructured":"Battula VL, Chen Y, Cabreira MG, Ruvolo V, Wang Z, Ma W, et al. Connective tissue growth factor regulates adipocyte differentiation of mesenchymal stromal cells and facilitates leukemia bone marrow engraftment. Blood. 2013;122:357\u201366.","journal-title":"Blood"},{"key":"278_CR22","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1080\/10428190802455875","volume":"49","author":"Z Zhi-Gang","year":"2008","unstructured":"Zhi-Gang Z, Wei-Ming L, Zhi-Chao C, Yong Y, Ping Z. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patient with hematological malignant diseases. Leuk Lymphoma. 2008;49:2187\u201395.","journal-title":"Leuk Lymphoma"},{"key":"278_CR23","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1158\/2159-8290.CD-12-0101","volume":"2","author":"HJ Li","year":"2012","unstructured":"Li HJ, Reinhardt F, Herschman HR, Weinberg RA. Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov. 2012;2:840\u201355.","journal-title":"Cancer Discov"},{"key":"278_CR24","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ijc.20877","volume":"115","author":"Y Denizot","year":"2005","unstructured":"Denizot Y, Donnard M, Truffinet V, Malissein E, Faucher JL, Turlure P, et al. Functional EP2 receptors on blast cells of patients with acute leukemia. Int J Cancer. 2005;115:499\u2013501.","journal-title":"Int J Cancer"},{"key":"278_CR25","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1016\/j.leukres.2005.12.017","volume":"30","author":"E Malissein","year":"2006","unstructured":"Malissein E, Reynaud S, Bordessoule D, Faucher JL, Turlure P, Trimoreau F, et al. PGE(2) receptor subtype functionality on immature forms of human leukemic blasts. Leuk Res. 2006;30:1309\u201313.","journal-title":"Leuk Res"},{"key":"278_CR26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc2809","volume":"10","author":"D Wang","year":"2010","unstructured":"Wang D, Dubois RN. Eicosanoids and cancer. Nat Rev Cancer. 2010;10:181\u201393.","journal-title":"Nat Rev Cancer"},{"key":"278_CR27","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1194\/jlr.M019695","volume":"53","author":"S Alcolea","year":"2012","unstructured":"Alcolea S, Anton R, Camacho M, Soler M, Alfranca A, Aviles-Jurado FX, et al. Interaction between head and neck squamous cell carcinoma cells and fibroblasts in the biosynthesis of PGE2. J Lipid Res. 2012;53:630\u201342.","journal-title":"J Lipid Res"},{"key":"278_CR28","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1093\/carcin\/bgp014","volume":"30","author":"A Greenhough","year":"2009","unstructured":"Greenhough A, Smartt HJ, Moore AE, Roberts HR, Williams AC, Paraskeva C, et al. The COX-2\/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis. 2009;30:377\u201386.","journal-title":"Carcinogenesis"},{"key":"278_CR29","doi-asserted-by":"publisher","first-page":"4584","DOI":"10.1073\/pnas.95.8.4584","volume":"95","author":"AM Ford","year":"1998","unstructured":"Ford AM, Bennett CA, Price CM, Bruin MC, Van Wering ER, Greaves M. Fetal origins of the TEL-AML1 fusion gene in identical twins with leukemia. Proc Natl Acad Sci U S A. 1998;95:4584\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"278_CR30","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrc1164","volume":"3","author":"MF Greaves","year":"2003","unstructured":"Greaves MF, Wiemels J. Origins of chromosome translocations in childhood leukaemia. Nat Rev Cancer. 2003;3:639\u201349.","journal-title":"Nat Rev Cancer"},{"key":"278_CR31","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1182\/blood.V94.3.1057.415k10_1057_1062","volume":"94","author":"JL Wiemels","year":"1999","unstructured":"Wiemels JL, Ford AM, Van Wering ER, Postma A, Greaves M. Protracted and variable latency of acute lymphoblastic leukemia after TEL-AML1 gene fusion in utero. Blood. 1999;94:1057\u201362.","journal-title":"Blood"},{"key":"278_CR32","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1038\/leu.2013.345","volume":"28","author":"U Kaindl","year":"2014","unstructured":"Kaindl U, Morak M, Portsmouth C, Mecklenbrauker A, Kauer M, Zeginigg M, et al. Blocking ETV6\/RUNX1-induced MDM2 overexpression by Nutlin-3 reactivates p53 signaling in childhood leukemia. Leukemia. 2014;28:600\u20138.","journal-title":"Leukemia"},{"key":"278_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/1874226200801010020","volume":"1","author":"B Nayjib","year":"2008","unstructured":"Nayjib B, Zeddou M, Drion P, Bonvier J, Tasken K, Rahmouni S, et al. In vivo administration of a PKA type I inhibitor (Rp-8-Br-cAMPS) restores T-cell responses in retrovirus-infected mice. The Open Immunology Journal. 2008;1:20\u20134.","journal-title":"The Open Immunology Journal"},{"key":"278_CR34","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/1476-4598-10-149","volume":"10","author":"KW Brudvik","year":"2011","unstructured":"Brudvik KW, Paulsen JE, Aandahl EM, Roald B, Tasken K. Protein kinase A antagonist inhibits beta-catenin nuclear translocation, c-Myc and COX-2 expression and tumor promotion in Apc(Min\/+) mice. Mol Cancer. 2011;10:149.","journal-title":"Mol Cancer"},{"key":"278_CR35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.18632\/oncotarget.952","volume":"4","author":"C Friesen","year":"2013","unstructured":"Friesen C, Roscher M, Hormann I, Fichtner I, Alt A, Hilger RA, et al. Cell death sensitization of leukemia cells by opioid receptor activation. Oncotarget. 2013;4:677\u201390.","journal-title":"Oncotarget"},{"key":"278_CR36","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0083-6729(09)81011-X","volume":"81","author":"R Malcher-Lopes","year":"2009","unstructured":"Malcher-Lopes R, Buzzi M. Glucocorticoid-regulated crosstalk between arachidonic acid and endocannabinoid biochemical pathways coordinates cognitive-, neuroimmune-, and energy homeostasis-related adaptations to stress. Vitam Horm. 2009;81:263\u2013313.","journal-title":"Vitam Horm"},{"key":"278_CR37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/JOE-11-0135","volume":"211","author":"G Schlossmacher","year":"2011","unstructured":"Schlossmacher G, Stevens A, White A. Glucocorticoid receptor-mediated apoptosis: mechanisms of resistance in cancer cells. J Endocrinol. 2011;211:17\u201325.","journal-title":"J Endocrinol"},{"key":"278_CR38","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/j.1440-1754.2011.02212.x","volume":"48","author":"VA Bhadri","year":"2012","unstructured":"Bhadri VA, Trahair TN, Lock RB. Glucocorticoid resistance in paediatric acute lymphoblastic leukaemia. J Paediatr Child Health. 2012;48:634\u201340.","journal-title":"J Paediatr Child Health"},{"key":"278_CR39","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1089\/scd.2013.0599","volume":"23","author":"M Sk\u00e5rn","year":"2014","unstructured":"Sk\u00e5rn M, Noordhuis P, Wang WY, Veuger M, Henrichson K, Egeland E, et al. Generation and characterization of an immortalized human mesenchymal stromal cell line. Stem Cells dev. 2014;23:2377\u201389.","journal-title":"Stem Cells dev."},{"key":"278_CR40","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/sj.onc.1201882","volume":"16","author":"CM Counter","year":"1998","unstructured":"Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA, et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene. 1998;16:1217\u201322.","journal-title":"Oncogene"},{"key":"278_CR41","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1002\/ijc.23833","volume":"123","author":"G Dosen-Dahl","year":"2008","unstructured":"Dosen-Dahl G, Munthe E, Nygren MK, Stubberud H, Hystad ME, Rian E. Bone marrow stroma cells regulate TIEG1 expression in acute lymphoblastic leukemia cells: role of TGFbeta\/BMP-6 and TIEG1 in chemotherapy escape. Int J Cancer. 2008;123:2759\u201366.","journal-title":"Int J Cancer"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-014-0278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12943-014-0278-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-014-0278-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-014-0278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T15:41:11Z","timestamp":1690904471000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-014-0278-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["278"],"URL":"https:\/\/doi.org\/10.1186\/s12943-014-0278-9","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,27]]},"assertion":[{"value":"4 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"14"}}